Profitability Ratios
| Ratio |
Value |
| GP Margin |
75.0% |
| EBIT Margin |
32.2% |
| EBITDA Margin |
41.9% |
| Operating Margin |
31.2% |
| Pretax Margin |
30.0% |
| Cont. Ops Margin |
25.6% |
| Net Margin |
25.6% |
| Bottom Line Margin |
25.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
1.12 |
| Quick Ratio |
0.89 |
| Solvency Ratio |
0.281 |
| Cash Ratio |
0.42 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
0.85 |
| Forward PEG |
0.85 |
| Price/Book |
5.79 |
| Price/Sales |
4.88 |
| Price/FCF |
15.11 |
| Price/Op Cash Flow |
13.89 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.3204 |
| Debt/Equity |
0.8028 |
| Debt/Capital |
0.4453 |
| Long-Term Debt/Capital |
0.3908 |
| Financial Leverage |
2.51 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
26.14 |
| Operating Cash Flow Ratio |
0.705 |
| Operating Cash Flow/Sales |
35.1% |
| Free Cash Flow/Operating Cash Flow |
91.9% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
2.95 |
| Interest Coverage |
14.3836 |
| Short-Term Operating Cash Flow Coverage |
3.33 |
| Operating Cash Flow Coverage |
0.52 |
| Capital Expenditure Coverage |
12.37 |
| Dividend + Capital Expenditure Coverage |
2.04 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
55.9068% |
| Dividend Yield |
2.9395% |
| Dividend Yield % |
2.9395% |
| Dividend Per Share |
4.0527 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
28.27 |
| EPS |
7.249 |
| Debt/Share |
19.7118 |
| Cash/Share |
5.98 |
| Book Value/Share |
24.01 |
| Tangible BV/Share |
-4.35 |
| Equity/Share |
23.79 |
| Operating Cash Flow/Share |
9.924 |
| Capital Expenditure/Share |
0.802 |
| FCF/Share |
9.121 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
0.855 |
| Earnings Before Tax/EBIT |
0.963 |
| Price/Fair Value |
5.79 |
| Debt/Market Cap |
0.1323 |
| Effective Tax Rate |
14.6% |
| Enterprise Value Multiple |
12.74 |
NVS - Novartis AG